Adage Capital Partners Gp, L.L.C. Aura Biosciences, Inc. Transaction History
Adage Capital Partners Gp, L.L.C.
- $52.3 Billion
- Q2 2024
A detailed history of Adage Capital Partners Gp, L.L.C. transactions in Aura Biosciences, Inc. stock. As of the latest transaction made, Adage Capital Partners Gp, L.L.C. holds 4,885,000 shares of AURA stock, worth $53.7 Million. This represents 0.07% of its overall portfolio holdings.
Number of Shares
4,885,000
Previous 4,465,000
9.41%
Holding current value
$53.7 Million
Previous $35.1 Million
5.36%
% of portfolio
0.07%
Previous 0.07%
Shares
10 transactions
Others Institutions Holding AURA
# of Institutions
79Shares Held
40.3MCall Options Held
800Put Options Held
1.8K-
Matrix Capital Management Company, LP Waltham, MA6.92MShares$76.2 Million0.4% of portfolio
-
Eventide Asset Management, LLC Boston, MA5.8MShares$63.8 Million0.77% of portfolio
-
Medicxi Ventures Management (Jersey) LTD3.04MShares$33.4 Million5.63% of portfolio
-
Black Rock Inc. New York, NY3.01MShares$33.1 Million0.0% of portfolio
-
Ken Griffin Citadel Advisors LLC | Chicago, Il2.34MShares$25.7 Million0.0% of portfolio
About Aura Biosciences, Inc.
- Ticker AURA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 29,273,600
- Market Cap $322M
- Description
- Aura Biosciences, Inc. operates as a biotechnology company that develops therapies to treat cancer. The company develops virus-like drug conjugates (VDC) technology platform for the treat tumors of high unmet need in ocular and urologic oncology. It develops AU-011, a VDC candidate for the treatment of primary choroidal melanoma. It also develop...